🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of the com...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12-15
Trial ID
NCT03342352
Treatments Being Tested
This is a multicenter, randomized, double-blinded, controlled Phase 3 trial...
Status
Active Not Recruiting
Location
Exelixis Clinical Site #116
Start Date
2019-06-25
Trial ID
NCT03937219
Treatments Being Tested
The primary purpose of this study is to compare the objective response rate...
Status
Completed
Location
San Francisco Oncology Associates
Start Date
2013-08-23
Trial ID
NCT01927419
Treatments Being Tested
The purpose of this study is to determine whether nivolumab is better than ...
Status
Completed
Location
Local Institution - 0036
Start Date
2015-03-16
Trial ID
NCT02388906
Treatments Being Tested
The purpose of this study is to show that Nivolumab and/or Nivolumab in com...
Status
Completed
Location
Local Institution - 0085
Start Date
2013-06-11
Trial ID
NCT01844505
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of the co...
Status
Terminated
Location
Pacific Cancer Medical Center, Inc
Start Date
2017-12-27
Trial ID
NCT03348904
Treatments Being Tested
The purpose of this study is to compare the clinical benefit, as measured b...
Status
Completed
Location
Fundacion Cidea
Start Date
2013-01-18
Trial ID
NCT01721772
This study is designed to evaluate the safety and tolerability of treatment...
Status
Completed
Location
The Angeles Clinic and Research Institute
Start Date
2019-01-28
Trial ID
NCT03817125
Treatments Being Tested
The purpose of this study is to see if BMS-986205 combined with nivolumab, ...
Status
Completed
Location
Angeles Clinic and Research Institute
Start Date
2017-11-30
Trial ID
NCT03329846
Treatments Being Tested